Bioxcel Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $3.1M | 1.1M | 2.82 |
| 2023-12-31 | $3.2M | 1.1M | 2.95 |
| 2023-09-30 | $3.1M | 1.2M | 2.53 |
| 2023-06-30 | $7.5M | 1.1M | 6.66 |
| 2023-03-31 | $20M | 1.1M | 18.66 |
| 2022-12-31 | $22M | 1.0M | 21.48 |
| 2022-06-30 | $13M | 996k | 13.20 |
| 2022-03-31 | $22M | 1.1M | 20.91 |
| 2021-09-30 | $29M | 968k | 30.35 |
| 2021-06-30 | $26M | 903k | 29.04 |
| 2021-03-31 | $34M | 789k | 43.15 |
| 2020-12-31 | $42M | 909k | 46.19 |
| 2020-09-30 | $38M | 871k | 43.36 |
| 2020-06-30 | $31M | 577k | 52.99 |
| 2020-03-31 | $11M | 491k | 22.35 |
| 2019-12-31 | $5.7M | 388k | 14.61 |
| 2019-09-30 | $2.7M | 383k | 7.04 |
| 2019-03-31 | $1.8M | 178k | 9.98 |
| 2018-12-31 | $194k | 58k | 3.33 |
| 2018-09-30 | $2.3M | 296k | 7.76 |
| 2018-06-30 | $2.7M | 301k | 8.87 |
| 2018-03-31 | $3.0M | 295k | 10.14 |